{"nct_id":"NCT02823405","title":"X4P-001 and Pembrolizumab in Patients With Advanced Melanoma","status":"COMPLETED","status_verified_date":"2020-07","start_date":"2016-09-15","start_date_type":"ACTUAL","primary_completion_date":"2018-03-15","primary_completion_date_type":"ACTUAL","completion_date":"2018-03-15","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["XFOR"]}